C-MER Medical Holdings (SEHK:3309) - Hisse Senedi Fiyatı, Haberler ve Analizler

3309 Stoklara Genel Bakış

Bir yatırım holding şirketi olan C-MER Medical Holdings Limited, Hong Kong ve Çin Anakarası'nda C-MER Dennis Lam markası altında oftalmik hizmetler sunmaktadır.

Şirket hakkında

3309 temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	3/6
Finansal Sağlık	5/6
Temettüler	0/6

Ödüller

Adil değer tahminimizden 77.9% daha düşük bir oranda işlem görüyor

Bu yıl karlı hale geldi

Risk Analizi

3309 risk kontrollerimizi geçti.

C-MER Medical Holdings Limited Rakipler

Chaoju Eye Care Holdings

SEHK:2219

HK$2.0b

Rici Healthcare Holdings

SEHK:1526

HK$1.9b

China Resources Medical Holdings

SEHK:1515

HK$5.3b

Honliv Healthcare Management Group

SEHK:9906

HK$1.4b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti C-MER Medical Holdings
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	HK$2.33
52 Haftanın En Yüksek Seviyesi	HK$3.98
52 Haftanın En Düşük Seviyesi	HK$1.81
Beta	0.56
11 Aylık Değişim	-16.49%
3 Aylık Değişim	-8.98%
1 Yıllık Değişim	-41.46%
33 Yıllık Değişim	-68.43%
5 Yıllık Değişim	-53.68%
Halka arzdan bu yana değişim	-54.40%

Son Haberler & Güncellemeler

Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Oct 18

Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

Sep 04

Recent updates

Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Oct 18

Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

Sep 04

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

May 21

C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

Apr 29

C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

Feb 02

C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

Jan 17

Hissedar Getirileri

	3309	HK Healthcare	HK Pazar
7D	0.4%	-1.5%	-1.0%
1Y	-41.5%	-23.5%	15.0%

Getiri vs. Endüstri: 3309 geçen yıl % -23.5 oranında getiri sağlayan Hong Kong Healthcare sektörünün gerisinde kaldı.

Getiri vs Piyasa: 3309 geçen yıl % 15 oranında getiri sağlayan Hong Kong Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is 3309's price volatile compared to industry and market?
3309 volatility
3309 Average Weekly Movement	9.1%
Healthcare Industry Average Movement	8.4%
Market Average Movement	9.0%
10% most volatile stocks in HK Market	19.0%
10% least volatile stocks in HK Market	4.3%

İstikrarlı Hisse Senedi Fiyatı: 3309 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 3309 'nin haftalık oynaklığı ( 9% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2012	2,192	Dennis Lam	www.cmermedical.com

Bir yatırım holding şirketi olan C-MER Medical Holdings Limited, Hong Kong ve Çin Anakarası'nda C-MER Dennis Lam markası altında oftalmik hizmetler sunmaktadır. Şirket dört segmentte faaliyet göstermektedir: HK Medikal İşletmesi, Tıbbi Sarf Malzemesi Satışı, Çin Anakarası Oftalmik İşletmesi ve Çin Anakarası Dental İşletmesi. Diş, onkoloji, medikal estetik ve laboratuvar hizmetleri sunar; gözlük ve lens gibi görmeye yardımcı ürünlerin ve tıbbi sarf malzemelerinin satışını gerçekleştirir.

C-MER Medical Holdings Limited Temel Bilgiler Özeti

C-MER Medical Holdings'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
3309 temel i̇stati̇sti̇kler
Piyasa değeri	HK$2.86b
Kazançlar(TTM)	HK$63.00m
Gelir(TTM)	HK$1.90b

45.4x

F/K Oranı

1.5x

P/S Oranı

3309 aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
3309 gelir tablosu (TTM)
Gelir	HK$1.90b
Gelir Maliyeti	HK$1.29b
Brüt Kâr	HK$607.94m
Diğer Giderler	HK$544.93m
Kazançlar	HK$63.00m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.051
Brüt Marj	32.06%
Net Kâr Marjı	3.32%
Borç/Özkaynak Oranı	1.0%

3309 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

3309 Stoklara Genel Bakış

Ödüller

Risk Analizi

C-MER Medical Holdings Limited Rakipler

SEHK:2219

HK$2.0b

SEHK:1526

HK$1.9b

SEHK:1515

HK$5.3b

SEHK:9906

HK$1.4b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Investor sentiment improves as stock rises 32%

Chairman & CEO recently bought HK$776k worth of stock

Investor sentiment deteriorates as stock falls 18%

Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

First half 2024 earnings released: EPS: HK$0.025 (vs HK$0.024 in 1H 2023)

Recent updates

Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Investor sentiment improves as stock rises 32%

Chairman & CEO recently bought HK$776k worth of stock

Investor sentiment deteriorates as stock falls 18%

Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

First half 2024 earnings released: EPS: HK$0.025 (vs HK$0.024 in 1H 2023)

C-MER Medical Holdings Limited to Report First Half, 2024 Results on Aug 29, 2024

Chairman & CEO recently bought HK$841k worth of stock

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

C-MER Eye Care Holdings Limited, Annual General Meeting, May 28, 2024

New major risk - Revenue and earnings growth

C-MER Eye Care Holdings Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

Price target decreased by 12% to HK$4.50

First half 2023 earnings released: EPS: HK$0.024 (vs HK$0.012 in 1H 2022)

C-MER Eye Care Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

C-MER Eye Care Holdings Limited to Report First Half, 2023 Results on Aug 30, 2023

C-MER Eye Care Holdings Limited Announces Board Changes, Effective July 3, 2023

Insufficient new directors

Now 21% undervalued after recent price drop

Now 22% undervalued after recent price drop

A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)

Full year 2022 earnings released: HK$0.018 loss per share (vs HK$0.019 profit in FY 2021)

Now 22% undervalued

Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal

Insufficient new directors

Chairman & CEO recently bought HK$1.9m worth of stock

Chairman & CEO recently bought HK$1.3m worth of stock

Insufficient new directors

Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?

First half 2022 earnings released: EPS: HK$0.012 (vs HK$0.012 in 1H 2021)

Insufficient new directors

C-MER Eye Care Holdings Limited to Report First Half, 2022 Results on Aug 30, 2022

C-MER Eye Care Holdings Limited, Annual General Meeting, May 24, 2022

Full year 2021 earnings released: EPS: HK$0.019 (vs HK$0.006 loss in FY 2020)

C-MER Eye Care Holdings Limited Recommends No Payment of Any Final Dividend for the Year Ended 31 December 2021

C-MER Eye Care Holdings Limited (SEHK:3309) entered into the Sale and Purchase agreements to acquire Champion Eye Centre Limited from Yeung, Hung, Pauline Chan, Ko, DN Chan,Yip, and the Estate of Cheung for HKD 56.02 million.

Executive Director exercised options to buy HK$1.7m worth of stock.

C-MER Eye Care Holdings Limited (SEHK:3309) entered into an Equity Transfer Agreement to acquire 7% stake in Shenzhen Aikangjian Group Co., Ltd. from Shenzhen Capital Group Co., Ltd. for CNY 45.5 million

First half 2021 earnings released: EPS HK$0.012 (vs HK$0.02 loss in 1H 2020)

C-MER Eye Care Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Independent Non-Executive Director recently bought HK$1.6m worth of stock

C-MER Eye Care Holdings Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.02 per share

Full year 2020 earnings released: HK$0.006 loss per share (vs HK$0.04 profit in FY 2019)

Full year 2020 earnings released: HK$0.006 loss per share (vs HK$0.04 profit in FY 2019)

C-MER Eye Care Holdings Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: HK$6.89

C-MER Eye Care Holdings Limited (SEHK:3309) signed a Purchase Agreement to acquire 60% stake in CAD/CAM Restorative Dental Centre Limited from YIU Bun Ka for HK$12.9 million.

New 90-day high: HK$6.44

Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year

Independent Non-Executive Director recently bought HK$1.8m worth of stock

C-MER Eye Care Holdings Limited Announces Board Changes

New 90-day low: HK$5.58

Independent Non-Executive Director recently bought HK$208k worth of stock

New 90-day low: HK$5.86

First half earnings released